AXA IM Alts, the alternative investor with €188 billion of assets under management, has promoted Steijn Ribbens to chief executive of Kadans Science Partner, its life sciences development business.
Kadans ties up Ribbens CEO promotion
Current chief investment officer steps up as Michel Leemhuis changes roles
By Luke Haynes
CoStar NewsOctober 16, 2025 | 8:19 AM
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Kadans Life Science Tower
North Quay, London, LND